Polyphenols: Dietary assessment and role in the prevention of cancers

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 20, Issue 6, 2017, Pages 512-521

  Rothwell, Joseph A ^a   Knaze, Viktoria ^a   Zamora Ros, Raul ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

biomarker; cancer; databases; dietary assessment; flavonoids; polyphenols

Indexed keywords

FLAVONOID; ISOFLAVONE DERIVATIVE; POLYPHENOL; BIOLOGICAL MARKER; CATECHIN;

ASIA; BREAST CANCER; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RISK; COLORECTAL CANCER; DIETARY INTAKE; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; HUMAN; LUNG CANCER; MALIGNANT NEOPLASM; NUTRITIONAL ASSESSMENT; OVARY CANCER; PANCREAS CANCER; PRIMARY PREVENTION; PROSTATE CANCER; REVIEW; RISK REDUCTION; SOY FOOD; STOMACH CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHEMISTRY; DIET; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; META ANALYSIS (TOPIC); NEOPLASM; RISK FACTOR; SOYBEAN; TEA;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CATECHIN; DIET; EPIDEMIOLOGIC STUDIES; EVIDENCE-BASED MEDICINE; FLAVONOIDS; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; NUTRITION ASSESSMENT; POLYPHENOLS; RISK FACTORS; SOYBEANS; TEA;

EID: 85030760798     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000424     Document Type: Review

References (49)

1. Zamora-Ros R, Knaze V, Rothwell JA, et al. Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr 2016; 55:1359-1375.
2. Maru GB, Hudlikar RR, Kumar G, et al. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: from experimental models to clinical trials. World J Biol Chem 2016; 7:88-99.
3. Zamora-Ros R, Touillaud M, Rothwell JA, et al. Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr 2014; 100:11-26.
4. Pinto P, Santos CN. Worldwide (poly)phenol intake: assessment methods and identified gaps. Eur J Nutr 2017; 56:1393-1408.
5. Illner AK, Freisling H, Boeing H, et al. Review and evaluation of innovative technologies for measuring diet in nutritional epidemiology. Int J Epidemiol 2012; 41:1187-1203.
6. Rothwell JA, Medina-Remon A, Perez-Jimenez J, et al. Effects of food processing on polyphenol contents: a systematic analysis using Phenol-Explorer data. Mol Nutr Food Res 2015; 59:160-170.
7. Martnez-Huelamo M, Vallverdú-Queralt A, Di Lecce G, et al. Bioavailability of tomato polyphenols is enhanced by processing and fat addition: evidence from a randomized feeding trial. Mol Nutr Food Res 2016; 60:1578-1589.
8. Amawi H, Ashby CR Jr, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what's limiting? Chin J Cancer 2017; 36:50.
9. Achaintre D, Bulete A, Cren-Olive C, et al. Differential isotope labeling of 38 dietary polyphenols and their quantification in urine by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 2016; 88:2637-2644.
10. Rothwell JA, Fillatre Y, Martin JF, et al. New biomarkers of coffee consumption identified by the nontargeted metabolomic profiling of cohort study subjects. PLoS One 2014; 9:e93474.
11. Edmands WM, Ferrari P, Rothwell JA, et al. Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countries. Am J Clin Nutr 2015; 102:905-913.
12. Grosso G, Godos J, Lamuela-Raventos R, et al. A comprehensive metaanalysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol Nutr Food Res 2017; 61:1600930.
13. Lei L, Yang Y, He H, et al. Flavan-3-ols consumption and cancer risk: a metaanalysis of epidemiologic studies. Oncotarget 2016; 7:73573-73592.
14. Zamora-Ros R, Barupal DK, Rothwell JA, et al. Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int J Cancer 2017; 140:1836-1844.
15. He X, Sun LM. Dietary intake of flavonoid subclasses and risk of colorectal cancer: evidence from population studies. Oncotarget 2016; 7:26617-26627.
16. Xu M, Chen YM, Huang J, et al. Flavonoid intake from vegetables and fruits is inversely associated with colorectal cancer risk: a case-control study in China. Br J Nutr 2016; 116:1275-1287.
17. Chen Y, Wu Y, Du M, et al. An inverse association between tea consumption and colorectal cancer risk. Oncotarget 2017; 8:37367-37376.
18. Hedelin M, Lof M, Sandin S, et al. Prospective study of dietary phytoestrogen intake and the risk of colorectal cancer. Nutr Cancer 2016; 68:388-395.
19. Jiang RJF, Botma A, Rudolph A, et al. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies. Br J Nutr 2016; 116:2115-2128.
20. Yu Y, Jing X, Li H, et al. Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis. Sci Rep 2016; 6:25939.
21. Shin A, Lee J, Lee J, et al. Isoflavone and soyfood intake and colorectal cancer risk: a case-control study in Korea. PLoS One 2015; 10:e0143228.
22. TseG, Eslick GD. Soy and isoflavone consumption and risk of gastrointestinal cancer: a systematic review and meta-analysis. Eur J Nutr 2016; 55:63-73.
23. Núnez-Sánchez MA, Gonzá lez-Sarras A, Romo-Vaquero M, et al. Dietary phenolics against colorectal cancer-from promising preclinical results to poor translation into clinical trials: pitfalls and future needs. Mol Nutr Food Res 2015; 59:1274-1291.
24. Xie Y, Huang S, Su Y. Dietary flavonols intake and risk of esophageal and gastric cancer: a meta-analysis of epidemiological studies. Nutrients 2016; 8:91.
25. Golpour S, Rafie N, Safavi SM, Miraghajani M. Dietary isoflavones and gastric cancer: a brief review of current studies. J Res Med Sci 2015; 20:893-900.
26. Merida-Ortega A, Hernandez-Alcaraz C, Hernandez-Ramirez RU, et al. Phthalate exposure, flavonoid consumption and breast cancer risk among Mexican women. Environ Int 2016; 96:167-172.
27. Messina M. Impact of soy foods on the development of breast cancer and the prognosis of breast cancer patients. Forsch Komplementmed 2016; 23: 75-80.
28. Atkinson C, Ray RM, Li W, et al. Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China. Nutr Res 2016; 36:863-871.
29. Hua X, Yu L, You R, et al. Association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk: a meta-analysis. PLoS One 2016; 11:e0151134.
30. Mohammadi V, Dehghani S, Larijani B, Azadbakht L. Ovarian cancer risk and nonisoflavone flavonoids intake: a systematic review of epidemiological studies. J Res Med Sci 2016; 21:123.
31. Zhong XS, Ge J, Chen SW, et al. Association between dietary isoflavones in soy and legumes and endometrial cancer: a systematic review and metaanalysis. J Acad Nutr Diet 2016. [Epub ahead of print]
32. Guo K, Liang Z, Liu L, et al. Flavonoids intake and risk of prostate cancer: a meta-analysis of observational studies. Andrologia 2016; 48:1175-1182.
33. Guo Y, Zhi F, Chen P, et al. Green tea and the risk of prostate cancer: a systematic review and meta-analysis. Medicine (Baltimore) 2017; 96:e6426.
34. He J, Wang S, Zhou M, et al. Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies. World J Surg Oncol 2015; 13:231.
35. Nagata Y, Sugiyama Y, Fukuta F, et al. Relationship of serum levels and dietary intake of isoflavone, and the novel bacteriumSlackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men. Int Urol Nephrol 2016; 48:1453-1460.
36. Molina-Montes E, Sanchez MJ, Zamora-Ros R, et al. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer 2016; 139:1480-1492.
37. Nimptsch K, Zhang X, Cassidy A, et al. Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am J Clin Nutr 2016; 103:184-191.
38. Jun S, Shin S, Joung H. Estimation of dietary flavonoid intake and major food sources of Korean adults. Br J Nutr 2016; 115:480-489.
39. Cui L, Liu X, Tian Y, et al. Flavonoids, flavonoid subclasses, and esophageal cancer risk: a meta-analysis of epidemiologic studies. Nutrients 2016; 8:350.
40. Magne Nde CB, Zingue S, Winter E, et al. Flavonoids, breast cancer chemopreventive and/or chemotherapeutic agents. Curr Med Chem 2015; 22:3434-3446.
41. Rafieian-Kopaei M, Movahedi M. Breast cancer chemopreventive and chemotherapeutic effects of Camellia sinensis (green tea): an updated review. Electron Physician 2017; 9:3838-3844.
42. Xiang LP, Wang A, Ye JH, et al. Suppressive effects of tea catechins on breast cancer. Nutrients 2016; 8:E458.
43. Li M, Tse LA, ChanWC, et al. Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong. Cancer Epidemiol 2016; 40:73-78.
44. Ci Y, Qiao J, Han M. Molecular mechanisms and metabolomics of natural polyphenols interfering with breast cancer metastasis. Molecules 2016; 21:pii: E1634.
45. Amararathna M, Johnston MR, Rupasinghe HP. Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci 2016; 17:pii: E1352.
46. Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65:87-108.
47. Khan F, Niaz K, Maqbool F, et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 2016; 8:529.
48. Stewart BW, Bray F, Forman D, et al. Cancer prevention as part of precision medicine: 'plenty to be done'. Carcinogenesis 2016; 37:2-9.
49. Cho YA, Lee J, Oh JH, et al. Dietary flavonoids, CYP1A1 genetic variants, and the risk of colorectal cancer in a Korean population. Sci Rep 2017; 7:128.